140 related articles for article (PubMed ID: 10103218)
1. In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.
Sáez-Nieto JA; Vázquez JA
Antimicrob Agents Chemother; 1999 Apr; 43(4):983-4. PubMed ID: 10103218
[TBL] [Abstract][Full Text] [Related]
2. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
Pankuch GA; Hoellman DB; Lin G; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250
[TBL] [Abstract][Full Text] [Related]
3. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains.
Biedenbach DJ; Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):349-53. PubMed ID: 9635909
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.
Wootton M; Bowker KE; Janowska A; Holt HA; MacGowan AP
J Antimicrob Chemother; 1999 Oct; 44(4):445-53. PubMed ID: 10588304
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
Engler KH; Warner M; George RC
J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.
Bebear CM; Renaudin H; Bryskier A; Bebear C
Antimicrob Agents Chemother; 2000 Jul; 44(7):1980-2. PubMed ID: 10858366
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Hoban DJ; Zhanel GG; Karlowsky JA
Diagn Microbiol Infect Dis; 1999 Sep; 35(1):37-44. PubMed ID: 10529880
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
Malathum K; Coque TM; Singh KV; Murray BE
Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro efficacy of telithromycin (HMR 3647) and levofloxacin with 22 antibiotic compounds against Bosea and Afipia species.
La Scola B; Bryskier A; Raoult D
J Antimicrob Chemother; 2004 Apr; 53(4):683-5. PubMed ID: 14998981
[No Abstract] [Full Text] [Related]
10. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.
Agouridas C; Bonnefoy A; Chantot JF
Antimicrob Agents Chemother; 1997 Oct; 41(10):2149-58. PubMed ID: 9333040
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
Reinert RR; Bryskier A; Lütticken R
Antimicrob Agents Chemother; 1998 Jun; 42(6):1509-11. PubMed ID: 9624505
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
Schülin T; Wennersten CB; Ferraro MJ; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 1998 Jun; 42(6):1520-3. PubMed ID: 9624509
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
Jamjian C; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 1998 Aug; 42(8):2138-40. PubMed ID: 9687424
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
J Antimicrob Chemother; 2000 Nov; 46(5):797-802. PubMed ID: 11062201
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 1998 Feb; 41(2):149-53. PubMed ID: 9533455
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4.
Rastogi N; Goh KS; Berchel M; Bryskier A
Antimicrob Agents Chemother; 2000 Oct; 44(10):2848-52. PubMed ID: 10991870
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
